OMED - Oncomed Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - OMED (1302573)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
31 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S19-5-22-44-34

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-10-10
OMEDPatel SunilSee RemarksS - Sale$4.24-1,24868,336-2%-$5,295
2017-10-10
OMEDHastings Paul JCOB, CEOS - Sale$4.24-1,398401,0280%-$5,931
2017-10-10
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale$4.24-1,248159,363-1%-$5,295
2017-10-10
OMEDGurney AustinSee RemarksS - Sale$4.24-1,24880,817-2%-$5,295
2017-10-10
OMEDHager Alicia J.SVP, GCS - Sale$4.24-1,24858,647-2%-$5,295
2017-06-05
OMEDKarsen Perry ADirP - Purchase$3.46+10,00010,000New+$34,588
2017-05-25
OMEDLasersohn Jack WDirP - Purchase$3.37+34,6141,685,913+2%+$116,639
M
2017-05-24
OMEDRoot Jonathan DDirS - Sale$3.71-13,880121,020-10%-$51,441
2017-05-23
OMEDLasersohn Jack WDirP - Purchase$3.55+20,0001,651,299+1%+$71,000
2017-05-19
OMEDRoot Jonathan DDirS - Sale$3.70-7,487134,900-5%-$27,712
2017-05-16
OMEDLasersohn Jack WDirP - Purchase$3.49+23,5071,631,299+1%+$82,061
2017-05-16
OMEDRoot Jonathan DDirS - Sale$3.58-6,900142,387-5%-$24,714
2017-04-04
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale$9.06-5,754111,888-5%-$52,113+3-41-56
2017-04-04
OMEDGurney AustinSee RemarksS - Sale$9.06-5,75443,301-12%-$52,113+3-41-56
2017-04-04
OMEDPatel SunilSee RemarksS - Sale$9.06-5,75424,584-19%-$52,113+3-41-56
2017-04-04
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale$9.06-5,75457,225-9%-$52,113+3-41-56
2017-04-04
OMEDHager Alicia J.SVP, GCS - Sale$9.06-4,31621,561-17%-$39,089+3-41-56
2017-04-04
OMEDHastings Paul JCOB, CEOS - Sale$9.06-6,473357,426-2%-$58,625+3-41-56
D
2017-03-15
OMEDHager Alicia J.SVP, GCS - Sale+OE$10.00-6,65225,877-20%-$66,520-3-8-59
DM
2017-01-05
OMEDHastings Paul JCOB, CEOS - Sale+OE$8.34-42,738362,163-11%-$356,559+1-8-9
D
2017-01-03
OMEDLewicki John A.EVP, Research, DevelopmentS - Sale+OE$7.63-9,175116,451-7%-$70,045+5-2-1
D
2017-01-03
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale+OE$7.64-12,76360,979-17%-$97,448+5-2-1
D
2016-11-16
OMEDHoey TimothySVP, Cancer Biology, Co-CSOS - Sale+OE$9.89-12,50060,979-17%-$123,609-2-1-20
D
2016-01-11
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale+OE$20.01-2,50020,642-11%-$50,021-13-10-47-24
M
2016-01-06
OMEDDupont JakobSVP, Chief Medical OfficerS - Sale$22.28-2,16220,642-9%-$48,160-15-21-52-35
M
2016-01-06
OMEDGurney AustinSee RemarksS - Sale$22.28-2,16233,257-6%-$48,160-15-21-52-35
M
2016-01-06
OMEDHoey TimothySVP, Cancer BiologyS - Sale$22.28-2,16247,181-4%-$48,162-15-21-52-35
2016-01-06
OMEDHastings Paul JCOB, CEOS - Sale$22.28-2,412346,865-1%-$53,731-15-21-52-35
M
2016-01-06
OMEDHager Alicia J.VP, GCS - Sale$22.28-1,62313,377-11%-$36,153-15-21-52-35
M
2016-01-06
OMEDPatel SunilSee RemarksS - Sale$22.28-2,16217,838-11%-$48,168-15-21-52-35
M
2016-01-06
OMEDLewicki John A.EVP, Chief Scientific OfficerS - Sale$22.28-2,162102,653-2%-$48,162-15-21-52-35

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top